Shedding light on rare diseases: open data and model organisms
Rare diseases pose a significant global health challenge, with the diagnostic journey often lasting years and causing immense burden on patients and healthcare systems. The complexity stems from the high proportion of genetic causes and the difficulty in linking specific gene variants to clinical outcomes. Establishing these connections is essential for early diagnosis and effective care, yet it remains a major obstacle due the limited availability of direct human biological data for many conditions. To bridge this knowledge gap, scientists rely on model organisms like mice to validate genetic findings and understand disease mechanisms. By altering genes in these models, researchers can observe phenotypic effects that mirror human conditions, providing crucial insights into disease pathology and potential therapies. This approach allows for the testing of therapeutic strategies and accelerates the development of treatments that would be unethical or impossible to study directly in humans. The success of this model depends heavily on open data initiatives that make biological information accessible and interoperable. Institutions like EMBL-EBI coordinate resources such as the Mouse Phenotype Informatics Infrastructure and PDCM Finder, ensuring data adheres to FAIR principles. This open sharing enables algorithms to integrate cross-species data with patient genomics, significantly improving diagnostic pipelines and driving progress in rare disease research and clinical care worldwide.
Source: miragenews.comPublished on 2023-03-01
Related news
- Public Records Request Nets User's Manual For Palantir's Souped-Up Surveillance Software
- Número de defunciones en el país sigue alto: Inegi
- FDA sued for concealing information about children's off-label use of puberty blockers, cross-sex hormones
- Two Norwalk Dems allege Council majority violates open meeting laws
- JPMorgan is scapegoating her with its fraud suit, Frank founder says